한글목차

2023년 아시아태평양 차세대 체외진단(IVD) 시장 규모는 214억 3,000만 달러에 달할 것으로 예상됩니다.

이 시장은 2033년 423억 5,000만 달러에 달할 것으로 예상되며, 2023-2033년 CAGR은 7.05%에 달할 것으로 예측됩니다. 진단학 분야의 혁신 기술의 출현은 차세대 체외진단(IVD) 시장의 성장을 촉진할 수 있는 잠재력을 가지고 있습니다. 분자 진단, 유전체학, 차세대 염기서열 분석(NGS)은 이러한 성장을 촉진하는 데 매우 중요한 역할을 할 것으로 예상되며, 질병 검출을 향상시키고 궁극적으로 환자 결과를 변화시킬 수 있는 새로운 기회를 제공할 것으로 예상됩니다.

아시아태평양은 차세대 체외진단(IVD) 시장에서 괄목할 만한 성장세를 보이고 있습니다. 이러한 성장에는 몇 가지 중요한 요인이 있습니다. 첫째, 만성 질환과 감염성 질환의 증가로 인해 보다 정확하고 효율적인 진단 솔루션이 요구되고 있습니다. 둘째, 중국, 인도, 일본과 같은 국가들의 급속한 도시화와 의료비 증가로 인해 첨단 진단 기술의 채택이 가속화되고 있습니다. 셋째, 개인 맞춤형 의료와 질병 조기 발견의 이점에 대한 의료진과 환자들의 인식이 높아지면서 혁신적인 IVD 솔루션에 대한 수요가 증가하고 있습니다. 또한, 의료 인프라를 개선하고 R&D 활동을 촉진하기 위한 정부 지원책도 아시아태평양의 시장 성장에 기여하고 있습니다.

이 보고서는 아시아태평양의 차세대 IVD 시장을 조사하여 시장 개요와 함께 유형별, 최종사용자별, 국가별 동향, 시장 진입 기업 개요 등을 제공합니다.

목차

주요 요약

제1장 시장

• 제품의 정의
• 시장 범위
• 조사 방법

제2장 시장 개요

• 서론
• COVID-19에 의한 차세대 IVD 시장에 대한 영향

제3장 업계 분석

• 법적 요건
  • 아시아태평양의 법적 요건과 체계

제4장 차세대 IVD 시장, 지역별, 100만 달러, 2022-2033년

• 개요
• 아시아태평양
  • 시장 역학
  • 시장 규모와 예측

제5장 기업 개요

• 차세대 IVD 시장 생태계의 활약 기업
• Sysmex Corporation

영문목차

The Asia-Pacific Next-Generation IVD Market Expected to Reach $42.35 Billion by 2033

Introduction to Asia-Pacific Next-Generation IVD (In vitro diagnostics) Market

The Asia-Pacific next-generation IVD market was valued at $21.43 billion in 2023 and is expected to reach $42.35 billion by 2033, growing at a CAGR of 7.05% between 2023 and 2033. The emergence of innovative technologies in diagnostics holds promise for revitalizing the growth of the next-generation In Vitro Diagnostics (IVD) market. Molecular diagnostics, genomics, and Next-Generation Sequencing (NGS) are anticipated to play pivotal roles in driving this growth, offering fresh opportunities for enhanced disease detection and ultimately transforming patient outcomes.

Market Introduction

The Asia-Pacific (APAC) region is witnessing significant advancements and growth in the Next-Generation In Vitro Diagnostics (IVD) market. This expansion is fueled by several key factors. Firstly, the increasing prevalence of chronic diseases and infectious ailments necessitates more accurate and efficient diagnostic solutions. Secondly, rapid urbanization and rising healthcare expenditures in countries like China, India, and Japan are driving the adoption of advanced diagnostic technologies. Thirdly, growing awareness among healthcare providers and patients regarding the benefits of personalized medicine and early disease detection is spurring demand for innovative IVD solutions. Additionally, supportive government initiatives aimed at improving healthcare infrastructure and promoting research and development activities further contribute to market growth in the APAC region.

Market Segmentation:

Segmentation 1: by Type

• Core Laboratory Diagnostics
• POC Testing
• Molecular Diagnostics

Segmentation 2: by End User

• Hospitals and Clinics
• Diagnostic Laboratories
• Academic and Research Institutions
• Other End Users

Segmentation 3: by Country

• Japan
• India
• China
• South Korea
• Australia
• Rest-of-Asia-Pacific

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The next-generation IVD market has been extensively segmented on the basis of various categories, such as type, end user, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The next-generation IVD market has numerous startups paving their way into manufacturing kits, panels, assays, and instruments and entering the market. Key players in the next-generation IVD market analyzed and profiled in the study involve established players that offer various kinds of disease-specific panels and multiplex instruments.

Table of Contents

Executive Summary

1 Markets

• 1.1 Product Definition
  • 1.1.1 Inclusion and Exclusion Criteria
• 1.2 Market Scope
  • 1.2.1 Key Questions Answered in the Report
• 1.3 Research Methodology
  • 1.3.1 Next-Generation IVD Market: Research Methodology
  • 1.3.2 Data Sources
    • 1.3.2.1 Primary Data Sources
    • 1.3.2.2 Secondary Data Sources
  • 1.3.3 Market Estimation Model
  • 1.3.4 Criteria for Company Profiling

2 Market Overview

• 2.1 Introduction
  • 2.1.1 Next-Generation IVD Market Outlook
    • 2.1.1.1 POC-IVD
    • 2.1.1.2 Diagnostic Expenditures
    • 2.1.1.3 Pricing Patterns of Next-Generation IVD
  • 2.1.2 Market Size and Growth Potential
    • 2.1.2.1 Short-Term Impact (2020-2025)
    • 2.1.2.2 Long-Term Impact (2026-2033)
  • 2.1.3 Product Benchmarking by Next- Generation In-vitro Diagnostics Market, (by Type)
• 2.2 COVID-19 Impact on the Next-Generation IVD Market
  • 2.2.1 Impact on Operations
  • 2.2.2 COVID-19 Impact: Current Scenario of the Market
  • 2.2.3 Pre-COVID Assessment
  • 2.2.4 Post-COVID-19 Market Assessment

3 Industry Analysis

• 3.1 Legal Requirements
  • 3.1.1 Legal Requirements and Framework in Asia-Pacific

4 Next-Generation IVD Market, by Region, $Million, 2022-2033

• 4.1 Overview
• 4.2 Asia-Pacific
  • 4.2.1 Market Dynamics
  • 4.2.2 Market Size and Forecast
    • 4.2.2.1 Asia-Pacific Next-Generation IVD Market (by End User)
    • 4.2.2.2 Asia-Pacific Next-Generation IVD Market (by Type)
      • 4.2.2.2.1 Asia-Pacific Next-Generation Core Laboratory IVD Market, (by Type)
    • 4.2.2.3 Asia-Pacific Next-Generation IVD Market (by Country)
      • 4.2.2.3.1 China
        • 4.2.2.3.1.1 Market Size and Forecast
        • 4.2.2.3.1.1.1 China Next-Generation IVD Market (by End User)
        • 4.2.2.3.1.1.2 China Next-Generation IVD Market (by Type)
      • 4.2.2.3.2 Japan
        • 4.2.2.3.2.1 Market Size and Forecast
        • 4.2.2.3.2.1.1 Japan Next-Generation IVD Market (by End User)
        • 4.2.2.3.2.1.2 Japan Next-Generation IVD Market (by Type)
      • 4.2.2.3.3 India
        • 4.2.2.3.3.1 Market Size and Forecast
        • 4.2.2.3.3.1.1 India Next-Generation IVD Market (by End User)
        • 4.2.2.3.3.1.2 India Next-Generation IVD Market (by Type)
      • 4.2.2.3.4 Australia
        • 4.2.2.3.4.1 Market Size and Forecast
        • 4.2.2.3.4.1.1 Australia Next-Generation IVD Market (by End User)
        • 4.2.2.3.4.1.2 Australia Next-Generation IVD Market (by Type)
      • 4.2.2.3.5 South Korea
        • 4.2.2.3.5.1 Market Size and Forecast
        • 4.2.2.3.5.1.1 South Korea Next-Generation IVD Market (by End User)
        • 4.2.2.3.5.1.2 South Korea Next-Generation IVD Market (by Type)
      • 4.2.2.3.6 Rest-of-Asia-Pacific
        • 4.2.2.3.6.1 Market Size and Forecast
        • 4.2.2.3.6.1.1 Rest-of-Asia-Pacific Next-Generation IVD Market (by End User)
        • 4.2.2.3.6.1.2 Rest-of-Asia-Pacific Next-Generation IVD Market (by Type)

5 Company Profiles

• 5.1 Overview
• 5.2 Next-Generation IVD Market Ecosystem Active Players
• 5.3 Sysmex Corporation
  • 5.3.1 Company Overview
  • 5.3.2 Role of Sysmex Corporation in the Next-Generation IVD Market
  • 5.3.3 Financials
  • 5.3.4 Recent Developments
    • 5.3.4.1 Business Strategies
  • 5.3.5 Analyst Perspective